Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation

Khadega A Abuelgasim^{1

2

3}, Moussab Damlaj^{4

5

6}, Mohammad Bosaeed⁷, Sumayyah Altamimi⁶, Hind Abdullah⁷, Reem M Ramli⁵, Rahma Alzahrani⁷, Nourah Alzughaibi⁸, Bader Alahmari^{4

5

6}, Ayman Alhejazi^{4

5

6}, Ahmed Alaskar^{4

5

6}, Mohsen Alzahrani^{4

5

6}

Affiliations

¹ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
² Oncology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
³ King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
⁴ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
⁵ Oncology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
⁶ King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
⁷ Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
⁸ Internal Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Khadega A Abuelgasim et al. Bone Marrow Transplant. 2021 Dec.

. 2021 Dec;56(12):3078-3080.

doi: 10.1038/s41409-021-01457-w. Epub 2021 Sep 10.

¹ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
² Oncology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
³ King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. ahmedkh1@ngha.med.sa.
⁴ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
⁵ Oncology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
⁶ King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
⁷ Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
⁸ Internal Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

No abstract available

References

1. Howard J. Sickle cell disease: when and how to transfuse. Hematol Am Soc Hematol Educ Program. 2016;2016:625–31. - DOI
1. Bhatia M, Sheth S. Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations. J Blood Med. 2015;6:229–38. - PubMed - PMC
1. Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, et al. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transpl. 2010;16:263–72. - DOI
1. Fitzhugh CD, Cordes S, Taylor T, Coles W, Roskom K, Link M, et al. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood. 2017;130:1946–8. - DOI
1. Busca A, Locatelli F, Barbui A, Ghisetti V, Cirillo D, Serra R, et al. Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2003;5:132–9. - DOI